David D. Chang

Insider Reports History

Location
South San Francisco, CA
Signature
/s/Earl Douglas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David D. Chang:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. President and CEO, Director Common Stock 5.28M $10.3M $1.96 14 Mar 2025 Direct
Allogene Therapeutics, Inc. President and CEO, Director Common Stock 1.2M $2.35M $1.96 14 Mar 2025 Indirect
Allogene Therapeutics, Inc. President and CEO, Director Stock Option (Right to buy) 1.95M 24 Jan 2025 Direct

Insider Reports Filed by David D. Chang

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALLO Allogene Therapeutics, Inc. 14 Mar 2025 1 -$91.5K 4 18 Mar 2025 President and CEO, Director
ALLO Allogene Therapeutics, Inc. 03 Feb 2025 1 -$77.3K 4 05 Feb 2025 President and CEO, Director
ALLO Allogene Therapeutics, Inc. 24 Jan 2025 2 $0 4 28 Jan 2025 President and CEO, Director
ALLO Allogene Therapeutics, Inc. 16 May 2024 1 $1M 4 20 May 2024 President and CEO, Director
ALLO Allogene Therapeutics, Inc. 14 Mar 2024 1 -$231K 4 18 Mar 2024 President and CEO, Director
ALLO Allogene Therapeutics, Inc. 25 Jan 2024 2 $0 4 31 Jan 2024 President and CEO, Director
ALLO Allogene Therapeutics, Inc. 22 Mar 2023 2 $0 4 24 Mar 2023 President and CEO, Director
ALLO Allogene Therapeutics, Inc. 14 Mar 2023 1 -$124K 4 16 Mar 2023 President and CEO, Director
ALLO Allogene Therapeutics, Inc. 23 Mar 2022 1 $0 4 25 Mar 2022 President and CEO, Director
ALLO Allogene Therapeutics, Inc. 15 Mar 2022 1 -$181K 4 17 Mar 2022 President and CEO, Director
ALLO Allogene Therapeutics, Inc. 24 May 2021 2 $499K 4 26 May 2021 President and CEO, Director